Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Brain Neoplasms × Cyclophosphamide × Clear all

Phase

Phase 2 12 Phase 1 11 Phase 3 3 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 39 Lymphoma, Non-Hodgkin 36 Lymphoma, Large B-Cell, Diffuse 36 Breast Neoplasms 35 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Multiple Myeloma 28 Melanoma 28 Leukemia 27 Leukemia, Lymphocytic, Chronic, B-Cell 26 Leukemia, Myeloid, Acute 23 Lymphoma, Follicular 22 Recurrence 21 Lymphoma, B-Cell 21 Lymphoma, Mantle-Cell 20 Ovarian Neoplasms 18 Neoplasm Metastasis 17 Hematologic Neoplasms 17 Pancreatic Neoplasms 16 Hodgkin Disease 16 Myelodysplastic Syndromes 15 Burkitt Lymphoma 14 Carcinoma, Non-Small-Cell Lung 13 Neoplasms 12 Colorectal Neoplasms 12 Lymphoma, B-Cell, Marginal Zone 10 Triple Negative Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Stomach Neoplasms 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma, Large-Cell, Immunoblastic 7

Interventions

Temozolomide 23 Radiosurgery 12 Bevacizumab 11 Carboplatin 8 pembrolizumab 7 Radiotherapy 7 Trastuzumab 6 Erlotinib Hydrochloride 5 abemaciclib 4 Paclitaxel 4 Capecitabine 4 tipifarnib 3 temsirolimus 3 Sirolimus 3 Radiation 3 Irinotecan 3 Ipilimumab 3 Everolimus 3 Aminolevulinic Acid 3 tucatinib 2 pertuzumab 2 durvalumab 2 alovudine 2 Vorinostat 2 Surgical Procedures, Operative 2 Sorafenib 2 Nivolumab 2 NVP-BKM120 2 Mental Status and Dementia Tests 2 Interleukin-2 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06640582 2024-11-05

BAH2472

Essen Biotech

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡